Asked of the wrong person at the wrong time, such a question could be taken as prurient impertinence, with face-reddening consequences for all concerned.But for diabetes patients, it could become as ...

The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug Blenrep, when used in combination with other treatments, may cause eye damage in ...